Arcus Biosciences Inc. (RCUS)
NYSE: RCUS
· Real-Time Price · USD
10.37
0.46 (4.64%)
At close: Aug 15, 2025, 3:59 PM
10.64
2.60%
After-hours: Aug 15, 2025, 07:29 PM EDT
Arcus Biosciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | n/a | -112M | -94M | -92M | -93M | -4M | -81M | -71M | -75M | -80M | -67.46M | -64.92M | -66.63M | -67.99M | 279.37M | -77.97M | -75.97M | -72.59M |
Depreciation & Amortization | 2M | 3M | 3M | 2M | 2M | 3M | 3M | 1M | 2M | 2M | 1.48M | 1.56M | 1.5M | 1.46M | -441K | 1.55M | 1.4M | 1.34M |
Stock-Based Compensation | 15M | 16M | 17M | 19M | 20M | 20M | 18M | 18M | 18M | 19M | 16.52M | 16M | 15M | 16.54M | 13.81M | 14.59M | 13.37M | 12.76M |
Other Working Capital | 45M | -45M | -24M | 45M | -26M | -42M | -9M | -32M | 19M | -48M | -21.54M | -29.71M | -23.06M | 689.32M | -360.94M | 8.55M | -2.41M | -16.05M |
Other Non-Cash Items | -187M | -2M | -3M | 41M | 13M | 2M | -20M | 27M | -2M | -1M | 252K | 966K | 3.25M | 6.54M | 5.44M | 1.39M | 906K | 506K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | 16M | -29M | 13M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 37M | -37M | -23M | 56M | -19M | -37M | -24M | -9M | -13M | -38M | -20.54M | -34.83M | -19.1M | 697.46M | -360.29M | 6.69M | -13.7M | -8.33M |
Operating Cash Flow | -133M | -132M | -100M | 26M | -94M | -2M | -88M | -63M | -57M | -98M | -69.74M | -80.96M | -65.3M | 654M | -62.1M | -53.76M | -74M | -66.32M |
Capital Expenditures | n/a | -1M | -1M | -1M | n/a | -4M | -6M | -10M | -5M | -3M | -880K | -1.32M | -7.01M | -2.79M | -8.51M | -7.86M | -6.07M | -3.64M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | 21M | -21M | -31M | -132M | n/a | n/a | 5.5M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -161M | -353M | -172M | -278M | -206M | -387M | -115M | -280M | -239M | -154M | -155.61M | -322.26M | -385.56M | -377.57M | -134.01M | -214.16M | -178.29M | -192.4M |
Sales Maturities Of Investments | 298M | 386M | 224M | 250M | 269M | 222M | 149M | 301M | 270M | 286M | 203.05M | 344.27M | 177.38M | 112.3M | 161.44M | 133.41M | 187.37M | 258.87M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | 63M | -165M | -21M | 21M | 31M | 132M | 250K | 2.75M | -5.5M | -265M | 27.21M | -80.75M | 9.08M | 66.47M |
Investing Cash Flow | 137M | 32M | 51M | -29M | 63M | -169M | 28M | 11M | 26M | 129M | 46.81M | 23.45M | -215.2M | -268.06M | 18.91M | -88.61M | 3M | 62.83M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | 1M | -1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 220.24M | n/a | -6K | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 52M | n/a | -2M | 48M | 2M | 1M | 3M | 1M | 3M | 1M | 11.2M | 3M | 4M | 15M | 11.67M | 1.32M | 2.24M | 1.89M |
Financial Cash Flow | 52M | 142M | -2M | 48M | 2M | 229M | 3M | 6M | 23M | 1M | 11M | 3M | 4M | 15M | 11.67M | 1.32M | 2.23M | 222.12M |
Net Cash Flow | 56M | 42M | -51M | 45M | -29M | 58M | -57M | -46M | -8M | 32M | -11.65M | -54.98M | -276.15M | 400.87M | -31.52M | -141.05M | -68.76M | 218.63M |
Free Cash Flow | -133M | -133M | -101M | 25M | -94M | -6M | -94M | -73M | -62M | -101M | -70.62M | -82.28M | -72.32M | 651.21M | -70.61M | -61.62M | -80.07M | -69.96M |